Arbutus Biopharma (ABUS) Ownership - Who Owns Arbutus Biopharma?

1,274 Followers

Arbutus Biopharma (ABUS) Ownership Overview

0.05% Insiders

9.73% Mutual Funds

28.16% Other Institutional Investors

10.59% ETFs

51.47% Public Companies and

Individual Investors

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 48.48% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 51.47% is owned by Public Companies and Individual Investors.

The ownership structure of Arbutus Biopharma (ABUS) stock is a mix of institutional, retail, and individual investors. Approximately 37.89% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 10.59% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Western Standard Llc	xxxxxxxxxxxxx	$2347142
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$9045774
Mar 31, 2024	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$495554

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	7,924,079	Institution	4.01%	34,469,744
	7,569,028	Institution	3.83%	32,925,272
	6,542,392	Institution	3.31%	28,459,405
	3,833,797	Institution	1.94%	16,677,017
	3,491,923	Institution	1.77%	15,189,865
	2,445,533	Institution	1.24%	10,638,069
Michael Rockefeller	2,010,172	Institution	1.02%	8,744,248
	1,606,012	Institution	0.81%	6,986,152
	1,559,360	Institution	0.79%	6,783,216
	903,143	Institution	0.46%	3,928,672

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
6,542,392	Institution	3.31%	28,459,405
3,833,797	Institution	1.94%	16,677,017
2,445,533	Institution	1.24%	10,638,069
1,606,012	Institution	0.81%	6,986,152
1,559,360	Institution	0.79%	6,783,216
903,143	Institution	0.46%	3,928,672
703,917	Institution	0.36%	3,062,039
484,841	Institution	0.25%	2,109,058
432,384	Institution	0.22%	1,880,870
121,867	Institution	0.06%	530,121

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	4,811,847	Institution	2.44%	20,209,757
iShares Russell 2000 ETF	3,597,065	Institution	1.82%	15,647,233
SPDR S&P BIOTECH ETF	2,520,688	Institution	1.28%	10,738,131
Vanguard Extended Market ETF	1,743,062	Institution	0.88%	7,320,860
iShares Russell 2000 Growth ETF	1,163,482	Institution	0.59%	5,061,147
iShares Biotechnology ETF	1,090,014	Institution	0.55%	4,741,561
Vanguard Russell 2000 ETF	764,654	Institution	0.39%	3,211,547
Schwab U.S. Small-Cap ETF	735,805	Institution	0.37%	3,134,529
SPDR S&P Kensho New Economies Composite ETF	622,640	Institution	0.32%	2,789,427
Vanguard Health Care ETF	430,645	Institution	0.22%	1,937,903

FAQ

Who Owns Arbutus Biopharma Corporation (ABUS)?

According to the latest TipRanks data, approximately 28.16% of the company's stock is held by institutional investors, 0.05% is held by insiders, and 51.47% is held by retail investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors?

According to the latest TipRanks data, approximately 28.16% of Arbutus Biopharma Corporation (ABUS) stock is held by institutional investors.

What percentage of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors?

According to the latest TipRanks data, approximately 51.47% of Arbutus Biopharma Corporation (ABUS) stock is held by retail investors.

Who owns the most shares of Arbutus Biopharma Corporation (ABUS)?

Vanguard owns the most shares of Arbutus Biopharma Corporation (ABUS).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.